Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2024
Estimation of health utility values for alopecia areataDaniel Aggio, Caleb Dixon, Ernest H Law, et al.Journal of Patient Experience|October 21, 2021
Voice Analysis of Cancer Experiences Among Patients With Breast Cancer: VOICE-BCErnest H Law, Maria J Auil, Patricia A Spears, et al.The Journal of Dermatological Treatment|February 3, 2025
Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trialErnest H Law, Kent A Hanson, Matthew Harries, et al.American Journal of Clinical Dermatology|October 23, 2024
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical TrialRodney Sinclair, Natasha Mesinkovska, Debanjali Mitra, et al.The Annals of Pharmacotherapy|October 14, 2016
Association Between Proton Pump Inhibitors and Microscopic ColitisErnest H Law, Melissa Badowski, Yu-Ting Hung, et al.Medical Care|March 22, 2022
Time-Specific Differences in Stated Preferences for Health in the United StatesErnest H Law, Alan Simon Pickard, Surrey M Walton, et al.Patient Preference and Adherence|March 29, 2021
Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice ExperimentKathleen Beusterien, Martine C Maculaitis, Bernadette Hallissey, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 8, 2018
Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value SetsErnest H Law, A Simon Pickard, Feng Xie, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in HungaryFanni Rencz, Valentin Brodszky, László Gulácsi, et al.Breast (Edinburgh, Scotland)|March 7, 2021
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysisElizabeth M Salvo, Abril Oliva Ramirez, Jenilee Cueto, et al.Pageof 5